CONGRATULATION FOR ACHIEVING SITE’S TARGET WITHIN THE STIPULATED TIMELINE [QUASAR]

Congratulations Prof. Dr. Ida Normiha Hilmi and the study team for achieving the site’s target within the stipulated timeline for QUASAR study!
Your hard work and dedication are deeply meaningful to UMMC and the nation.

Details of the study: https://clinicaltrials.gov/ct2/show/NCT04033445

 

Clinical Trials, Guselkumab, QUASAR, UlcerativeColitis

Share:

More Posts

Newsletter

Scroll to Top